T. Rowe Price Associates’s BioAtla BCAB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-12,791	Closed	-$45K	–	2934
2024 Q1	$45K	Buy	+12,791	New	+$45K	﹤0.01%	2882
2021 Q1	–	Sell	-638,480	Closed	-$21.7M	–	2841
2020 Q4	$21.7M	Buy	+638,480	New	+$21.7M	﹤0.01%	1207